dc.contributorRamírez Rivera, Yesid Andres
dc.creatorRamírez Rivera, Yesid Andres
dc.creatorRodríguez Soacha, Diego A
dc.creatorSteinmüller, Sophie AM
dc.creatorIşbilir, Ali
dc.creatorFender, Julia
dc.creatorDeventer, Marie H
dc.creatorTutov, Anna
dc.creatorSotriffer, Christoph
dc.creatorStove, Christophe P
dc.creatorLorenz, Kristina
dc.creatorLohse, Martín J
dc.creatorHislop, James N
dc.creatorDecker, Michael
dc.date.accessioned2023-08-04T19:23:19Z
dc.date.accessioned2023-09-06T16:58:53Z
dc.date.available2023-08-04T19:23:19Z
dc.date.available2023-09-06T16:58:53Z
dc.date.created2023-08-04T19:23:19Z
dc.date.issued2022-07-26
dc.identifierhttp://repository.icesi.edu.co/biblioteca_digital/handle/10906/104318
dc.identifierhttps://doi.org/10.1021/acschemneuro.2c00160
dc.identifierinstname: Universidad Icesi
dc.identifierreponame: Biblioteca Digital
dc.identifierrepourl: https://repository.icesi.edu.co/
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8688629
dc.description.abstractActivation of the human cannabinoid receptor type 1 (hCB1R) with high spatiotemporal control is useful to study processes involved in different pathologies related to nociception, metabolic alterations, and neurological disorders. To synthesize new agonist ligands for hCB1R, we have designed different classes of photoswitchable molecules based on an indole core. The modifications made to the central core have allowed us to understand the molecular characteristics necessary to design an agonist with optimal pharmacological properties. Compound 27a shows high affinity for CB1R (Ki (cis-form) = 0.18 μM), with a marked difference in affinity with respect to its inactive “trans-off” form (CB1R Kitrans/cis ratio = 5.4). The novel compounds were evaluated by radioligand binding studies, receptor internalization, sensor receptor activation (GRABeCB2.0), Western blots for analysis of ERK1/2 activation, NanoBiT βarr2 recruitment, and calcium mobilization assays, respectively. The data show that the novel agonist 27a is a candidate for studying the optical modulation of cannabinoid receptors (CBRs), serving as a new molecular tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system.
dc.languageeng
dc.publisherAmerican Chemical Society
dc.publisherEstados Unidos America
dc.relationPubMed: 35881914
dc.relationCS Chem. Neurosci. 2022 , 13 , 16 , 2410 - 2435
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.subjectphotorimonabant
dc.subjectoptical control
dc.subjectphotopharmacology
dc.subjectCB1 agonist
dc.subjectG-protein-coupled
dc.subjectreceptor
dc.subjectdiazocine
dc.titleDevelopment of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) “Cis-On” Agonist
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución